Literature DB >> 28723575

CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.

Rasmus O Bak1, Matthew H Porteus2.   

Abstract

The CRISPR/Cas9 system has recently been shown to facilitate high levels of precise genome editing using adeno-associated viral (AAV) vectors to serve as donor template DNA during homologous recombination (HR). However, the maximum AAV packaging capacity of ∼4.5 kb limits the donor size. Here, we overcome this constraint by showing that two co-transduced AAV vectors can serve as donors during consecutive HR events for the integration of large transgenes. Importantly, the method involves a single-step procedure applicable to primary cells with relevance to therapeutic genome editing. We use the methodology in primary human T cells and CD34+ hematopoietic stem and progenitor cells to site-specifically integrate an expression cassette that, as a single donor vector, would otherwise amount to a total of 6.5 kb. This approach now provides an efficient way to integrate large transgene cassettes into the genomes of primary human cells using HR-mediated genome editing with AAV vectors.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAV; CRISPR/Cas9; gene editing; genome; integration; large; long; sequential

Mesh:

Year:  2017        PMID: 28723575      PMCID: PMC5568673          DOI: 10.1016/j.celrep.2017.06.064

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  32 in total

1.  An mRNA surveillance mechanism that eliminates transcripts lacking termination codons.

Authors:  Pamela A Frischmeyer; Ambro van Hoof; Kathryn O'Donnell; Anthony L Guerrerio; Roy Parker; Harry C Dietz
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

2.  Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer.

Authors:  Brian D Brown; Mary Anna Venneri; Anna Zingale; Lucia Sergi Sergi; Luigi Naldini
Journal:  Nat Med       Date:  2006-04-23       Impact factor: 53.440

3.  Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.

Authors:  Christine Aurnhammer; Maren Haase; Nadine Muether; Martin Hausl; Christina Rauschhuber; Ingrid Huber; Hans Nitschko; Ulrich Busch; Andreas Sing; Anja Ehrhardt; Armin Baiker
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

Review 4.  Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.

Authors:  Kyle Chamberlain; Jalish Mahmud Riyad; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2016-02       Impact factor: 2.396

5.  CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.

Authors:  Suk See De Ravin; Linhong Li; Xiaolin Wu; Uimook Choi; Cornell Allen; Sherry Koontz; Janet Lee; Narda Theobald-Whiting; Jessica Chu; Mary Garofalo; Colin Sweeney; Lela Kardava; Susan Moir; Angelia Viley; Pachai Natarajan; Ling Su; Douglas Kuhns; Kol A Zarember; Madhusudan V Peshwa; Harry L Malech
Journal:  Sci Transl Med       Date:  2017-01-11       Impact factor: 17.956

6.  Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.

Authors:  A Barzel; N K Paulk; Y Shi; Y Huang; K Chu; F Zhang; P N Valdmanis; L P Spector; M H Porteus; K M Gaensler; M A Kay
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

7.  Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification.

Authors:  Friederike Knipping; Mark J Osborn; Karl Petri; Jakub Tolar; Hanno Glimm; Christof von Kalle; Manfred Schmidt; Richard Gabriel
Journal:  Mol Ther Methods Clin Dev       Date:  2017-02-12       Impact factor: 6.698

8.  A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.

Authors:  Yang Yang; Lili Wang; Peter Bell; Deirdre McMenamin; Zhenning He; John White; Hongwei Yu; Chenyu Xu; Hiroki Morizono; Kiran Musunuru; Mark L Batshaw; James M Wilson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

9.  Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.

Authors:  Jianbin Wang; Colin M Exline; Joshua J DeClercq; G Nicholas Llewellyn; Samuel B Hayward; Patrick Wai-Lun Li; David A Shivak; Richard T Surosky; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2015-11-09       Impact factor: 54.908

10.  Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Authors:  Hao Yin; Chun-Qing Song; Joseph R Dorkin; Lihua J Zhu; Yingxiang Li; Qiongqiong Wu; Angela Park; Junghoon Yang; Sneha Suresh; Aizhan Bizhanova; Ankit Gupta; Mehmet F Bolukbasi; Stephen Walsh; Roman L Bogorad; Guangping Gao; Zhiping Weng; Yizhou Dong; Victor Koteliansky; Scot A Wolfe; Robert Langer; Wen Xue; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  48 in total

1.  Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.

Authors:  Kiel T Butterfield; Patrick S McGrath; Chann Makara Han; Igor Kogut; Ganna Bilousova
Journal:  Methods Mol Biol       Date:  2020

Review 2.  Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.

Authors:  Lee A Campbell; Christopher T Richie; Nishad S Maggirwar; Brandon K Harvey
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-06       Impact factor: 4.147

3.  Synthetic biology advances and applications in the biotechnology industry: a perspective.

Authors:  Leonard Katz; Yvonne Y Chen; Ramon Gonzalez; Todd C Peterson; Huimin Zhao; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2018-06-18       Impact factor: 3.346

4.  AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs.

Authors:  Amanda M Dudek; Matthew H Porteus
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

5.  Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia.

Authors:  Hsuan-Ting Huang; Alejandro Roisman; Emmalee R Adelman; André Olsson; Antonio Colaprico; Tingting Qin; R Coleman Lindsley; Rafael Bejar; Nathan Salomonis; H Leighton Grimes; Maria E Figueroa
Journal:  Cancer Discov       Date:  2019-05-13       Impact factor: 39.397

6.  CRISPR-READI: Efficient Generation of Knockin Mice by CRISPR RNP Electroporation and AAV Donor Infection.

Authors:  Sean Chen; Sabrina Sun; Dewi Moonen; Clancy Lee; Angus Yiu-Fai Lee; David V Schaffer; Lin He
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

7.  CRISPR/Cas9 genome editing in human hematopoietic stem cells.

Authors:  Rasmus O Bak; Daniel P Dever; Matthew H Porteus
Journal:  Nat Protoc       Date:  2018-01-25       Impact factor: 13.491

8.  Engineered materials for in vivo delivery of genome-editing machinery.

Authors:  Sheng Tong; Buhle Moyo; Ciaran M Lee; Kam Leong; Gang Bao
Journal:  Nat Rev Mater       Date:  2019-10-04       Impact factor: 66.308

Review 9.  Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes.

Authors:  Gaelen T Hess; Josh Tycko; David Yao; Michael C Bassik
Journal:  Mol Cell       Date:  2017-10-05       Impact factor: 17.970

10.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.

Authors:  Emily J Pomeroy; John T Hunzeker; Mitchell G Kluesner; Walker S Lahr; Branden A Smeester; Margaret R Crosby; Cara-Lin Lonetree; Kenta Yamamoto; Laura Bendzick; Jeffrey S Miller; Melissa A Geller; Bruce Walcheck; Martin Felices; Beau R Webber; Timothy K Starr; Branden S Moriarity
Journal:  Mol Ther       Date:  2019-10-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.